The starting dose is 0.25 milligrams
Not long after her original discovery in the 1980s, Mojsov was looking at the results of supplemental GLP-1 testing in humans with a lab technician when she realized she was onto something big
This is actually one way the medication helpsit makes healthier choices feel more satisfying
The following data were obtained at baseline as well as three and six months (M3, M6) after initiation of the treatment with a GLP-1-RA + UCWM or UCWM alone: body weight, monthly headache days (MHD) recorded in a headache diary, and ophthalmological assessment including visual acuity, perimetry, fundoscopy, optical coherence tomography (OCT) and ocular ultrasonography
The diagnosis of postprandial hypoglycemia
Resealability, portion separation, freezer compatibility and durable secondary packs become practical ways to preserve value